Frank Minella's Email & Phone Number

💼 Past Experience

1. Subjective pain measurement through inaccurate patient self-reportPainQx is a neuro analytics platform being sold to the pre-commercial Clinical Research Market for use as a drug development tool, (i.e. a scaled pain biomarker, neurological side effect biomarker & placebo responder screen), providing early revenue, validation & advocacy from first users (Pharma & CROs). Upon FDA clearance, Clinical users will access PainQx tech on a pay-per-use or subscription basis. Our patented method for the objective, quantitative pain measurement is thePainQx platform. PainQx solves four problems:1) Subjective pain measurement through inaccurate patient self-report2) Measurement of pain in patient populations that cannot accurately articulate or express pain (e.g. unconscious, pediatric, elderly) or are unlikely to accurately describe the level of pain (e.g. misusers/abusers of prescription meds)3) Under-treatment of patient pain4) Over-treatment of patient pain, especially regarding over use of opioid/ analgesic drugs.2. Measurement of pain in patient populations that cannot accurately articulate or express painPainQx is a neuro analytics platform being sold to the pre-commercial Clinical Research Market for use as a drug development tool, (i.e. a scaled pain biomarker, neurological side effect biomarker & placebo responder screen), providing early revenue, validation & advocacy from first users (Pharma & CROs). Upon FDA clearance, Clinical users will access PainQx tech on a pay-per-use or subscription basis. Our patented method for the objective, quantitative pain measurement is thePainQx platform. PainQx solves four problems:1) Subjective pain measurement through inaccurate patient self-report2) Measurement of pain in patient populations that cannot accurately articulate or express pain (e.g. unconscious, pediatric, elderly) or are unlikely to accurately describe the level of pain (e.g. misusers/abusers of prescription meds)3) Under-treatment of patient pain4) Over-treatment of patient pain, especially regarding over use of opioid/ analgesic drugs.4. Over-reatment of patient pain, especially regarding over use of opioid/ analgesic drugsPainQx is a neuro analytics platform being sold to the pre-commercial Clinical Research Market for use as a drug development tool, (i.e. a scaled pain biomarker, neurological side effect biomarker & placebo responder screen), providing early revenue, validation & advocacy from first users (Pharma & CROs). Upon FDA clearance, Clinical users will access PainQx tech on a pay-per-use or subscription basis. Our patented method for the objective, quantitative pain measurement is thePainQx platform. PainQx solves four problems:1) Subjective pain measurement through inaccurate patient self-reporting2) Measurement of pain in patient populations that cannot accurately articulate or express pain (e.g. unconscious, pediatric, elderly) or are unlikely to accurately describe the level of pain (e.g. misusers/abusers of prescription meds)3) Under-treatment of patient pain4)

🎓 Education

Frank Minella is a Business Manager with a background in Accounting. After receiving his B.S. from the University of Scranton in 1986, Minella pursued a career in business administration, working as an accountant in various organizations until 1990, when he rejoined the United States Army as an officer basic course attendee at the U.S. Army Aviation Center of Excellence. After completing the initial entry rotary wing at the Aviation Center of Excellence, Minella earned his non-commissioned officer (NCO) badge and was promoted to warrant officer (WO). From there, Minella served as an Aviation officer in the United States Army Reserve, eventually serving as the commanding officer of an Army aviation squadron.In his civilian career, Frank Minella has primarily been involved in the aviation market. He has held various positions with a variety of aviation companies in both the private and public sectors. In his civilian career, Minella has held various positions with a variety of aviation companies in both the private and public sectors. As a business manager, Minella has cultivated relationships with a wide variety of customers and suppliers, both within the aviation sector and throughout the economy as a whole.Frank Minella's educational background and work readiness reflect his experience and expertise as a business manager. Minella has an extensive background in business administration and has worked as an accountant in various organizations. He is highly experienced in involving his customers and suppliers in various projects and has a strong relationship with numerous individuals and organizations. As a business manager, Minella is well-prepared to lead and manage large-scale business ventures.

💡 Technical & Interpersonal Skills

Summary:Frank Minella is currently a Commercial Airline Pilot at US Airways from January 2000 to May 2006 (6 years 5 months). First Officer / Pilot. Captain, Aviator, Battalion/ Squadron Operations Officer at US Army from September 1987 to January 2000 (12 years 5 months). U.S. Army Officer and Aviator. Medical Company (MEDEVAC), Aviation Attack Battalion and Cav. Squadron Flight Operations Officer in various units and locales over 12 proud years of Service.Frank Minella has experience in the Pharmaceutical Industry Sector, Business Analyst & Consultant in the Business Process and Change Management Groups, as well as Owning & Operating a Custom Pool Construction & Service Company. In his work experiences, he has developed a patented method for the objective, quantitative pain measurement of pain. PainQx is currently working with several best in class academic and commercial collaborators to develop empirical, replicable biomarkers for chronic pain.Frank Minella is ahighly experiencedCommercial Airline Pilot and First Officer/Pilot with over six years of experience in the Greater Philadelphia Area. He has also been a First Officer/Pilot with the United States Army for 12 years.